Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC

Published Date: 13 Sep 2024

However, plinabulin plus docetaxel still "not ready for prime time," expert says

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC

2.

AI Unlocks Benefits of Prostate Cancer Treatment.

3.

Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma

4.

Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.

5.

Is Exercise an Effective Treatment for Prostate Cancer?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot